Kurt Graves


Mr. Graves, joined Achillion’s Board of Directors in June 2012 and currently is a member of the Compensation Committee and the Strategy and Corporate Development Committee. Mr. Graves is Chairman, President and Chief Executive Officer of Intarcia Therapeutics, Inc. Prior to Intarsia, he held senior management roles at Merck, Novartis and Vertex Pharmaceuticals.